• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

New Staging System on Horizon for Head and Neck Cancers

by Thomas R. Collins • June 20, 2017

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Oral cavity cancer: The depth of invasion has been incorporated into the update, and will now increase the T category by one step for every 5 mm of invasion, Dr. Kraus said.

You Might Also Like

  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • ‘Patient-Centered Approach’ Delivers High-Quality Care to Patients with Head and Neck Cancers
  • Sarcopenia Significantly Associated with Poorer Overall Survival of Patients with Head and Neck Cancers
Explore This Issue
June 2017

Dr. Kraus hopes the staging changes will improve care. “I think this will have a significant impact on our patients [and] a significant impact upon where we decide to both intensify and de-intensify patient care.”

Robotic Surgery

In another segment of the panel session, J. Scott Magnuson, MD, the chief medical officer of the Florida Hospital Nicholson Center in Celebration, Fla., said the onward march continues in robotic surgery, fueled by new technology geared toward augmenting the knowledge and skill of human experts; new financial models in which price is aligned with value and that promote technology that will lower the cost of treatment rather than increase it; and new roles for surgeons in which this technology could help boost the patient–provider ratio.

Dr. Magnuson said that most of the robotic surgery technology now in use is at Level 1, which allows the operator to keep continuous control of the system while the robot helps in some way. However, there are already robots made, although these are not yet commercially available, that are at a Level 3. At this level, the operator selects and approves a plan, and the robot performs the procedure automatically under close supervision. One such robot can suture after the surgeon sets it up, he added.

Another robot in the design phase is being devised to reach a Level 4—it is even able to make decisions, although it’s still under close supervision. “The ‘surgical cockpit’ is really the future for us,” Dr. Magnuson said. “If we’re to compare this to the airline industry and what pilots have— they’ve gone from manual control to computer controls to where the plane is flown automatically.”

Checkpoint Therapies

Ravi Uppalurri, MD, PhD, director of head and neck surgical oncology at the Dana Farber Cancer Institute in Boston, discussed the evolving role of checkpoint inhibition in the treatment of head and neck cancer, including the use of these therapies prior to surgery.

The therapies—which include nivolumab and pembrolizumab—have been shown to overcome the way in which a tumor can blunt the body’s immune response to cancer. They essentially “release the brakes” in the immune system’s fight against the tumor and have been shown to have lasting responses.

Some patients have had dramatic success with these types of therapy, with complete eradication of cancer in the neck, he said. “Ultimately, these kinds of vignettes really need to be confirmed with larger trials,” he added. “But I think these kinds of neoadjuvant approaches are really going to change how we manage our patients.”

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features Tagged With: cancer staging, cancer therapy, head and neck cancer, Triological Society annual meetingIssue: June 2017

You Might Also Like:

  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • ‘Patient-Centered Approach’ Delivers High-Quality Care to Patients with Head and Neck Cancers
  • Sarcopenia Significantly Associated with Poorer Overall Survival of Patients with Head and Neck Cancers

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use AI-powered scribes for documentation?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • How to: Positioning for Middle Cranial Fossa Repair of Superior Semicircular Canal Dehiscence

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • The Importance of Time Away
    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 
    • Reflections from a Past President of the Triological Society
    • ENT Surgeons Explore the Benefits and Challenges of AI-Powered Scribes: Revolutionizing Documentation in Healthcare
    • How To: Open Expansion Laryngoplasty for Combined Glottic and Subglottic Stenosis

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939